10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection [Onivyde]
- RxCUI
- 1719777
- RxNorm name
- 10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection [Onivyde]
- Display name
- 10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection [Onivyde]
- Full name
- 10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection [Onivyde]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Onivyde | IRINOTECAN HYDROCHLORIDE | Ipsen Biopharmaceuticals, Inc. | c8b58efa-1820-48a4-b70d-62918fc4abfc | 2025-03-03 | Boxed warning, Warnings, Adverse reactions | 1719777 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c8b58efa-1820-48a4-b70d-62918fc4abfc | Onivyde 43 MG in 10 ML Injection [PSN] · 10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection [Onivyde] [SBD] · 10 ML Onivyde 4.3 MG/ML Injection [SY] · Onivyde 43 MG per 10 ML Injection [SY] | 4 | 9 | These highlights do not include all the information needed to use ONIVYDE safely and effectively. See full prescribing information for ONIVYDE ONIVYDE® (irinotecan liposome injection), for intravenous use Initial U.S. Approval: 1996 | 20250303 |